Your session is about to expire
← Back to Search
Antiplatelet Treatment Discontinuation After PFO Closure for Stroke (HALTI Trial)
HALTI Trial Summary
This trial looks at whether it's safe to stop taking blood-thinners after having a transcatheter PFO closure, 12 months after the procedure.
HALTI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowHALTI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.HALTI Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I had a stroke or mini-stroke within a year after my PFO closure.You have already had a successful closure of a hole in your heart using a special device.I have diabetes.I have a blood clotting disorder.I am 60 or younger and had a stroke/TIA treated by closing a hole in my heart.Your RoPE score is less than 6.I am over 60 years old.I still have a moderate or larger hole in my heart after surgery.You have atrial fibrillation after a PFO closure procedure.I have two or more heart disease risk factors like smoking, high blood pressure, or high cholesterol.
- Group 1: Antiplatelet treatment discontinuation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the eligibility criterion for this experiment encompass individuals over 30?
"This study is recruiting individuals who are of legal age and younger than 60 years old."
Is this trial open to recruitment at the moment?
"Clinicaltrials.gov has confirmed that this clinical trial is still seeking participants, with the first post made on July 8th 2020 and most recent update on September 21st 2021."
What are the stated objectives of this research project?
"This clinical trial, monitored for a period of two years, is designed to assess stroke events. Secondary aims are the number and volume of cerebral ischemic lesions evaluated through MRI as well as the total count of strokes and transient ischemia attacks (TIAs)."
To what population is this trial open?
"100 prospective patients are qualified to join this trial, provided they have suffered from a wake-up stroke and fall within the age parameter of 18 - 60 years old."
What is the current number of participants for this clinical research?
"Affirmative. According to clinicaltrials.gov, this medical research project is still recruiting participants from one location and requires 100 volunteers. The trial was first published on July 8th 2020 with the most recent edits being done on September 21st 2021."
Who else is applying?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger